ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.704,41
0,38%
S&P 500
6.039,31
-0,47%
Dow Jones
44.713,52
-0,31%
Euro vs US Dollar
1,04208
-0,04%
Bitcoin
105.221,01
1,43%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Elite Pharmaceuticals Inc (QB) (ELTP) Börsenkurse

Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

USOTC
0,46805
0,00505
(1,09%)
Geschlossen 30 Januar 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,46805
Gebot
0,4661
Fragen
0,479
Volumen
791.673
0,45 Tagesbereich 0,4699
0,1213 52-Wochen-Bereich 0,7598
Marktkapitalisierung
500,005M
Handelsende
0,463
Handelsbeginn
0,45275
Letzte Trade
1
@
0.46805
Letzter Handelszeitpunkt
Finanzvolumen
US$ 363.142
VWAP
0,458702
Durchschnittliches Volumen (3 Mio.)
1.637.968
Ausgegebene Aktien
1.068.273.108
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
25,00
Gewinn pro Aktie (EPS)
0,02
Erlöse
56,63M
Nettogewinn
20,11M

Über Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.elitepharma.com
Hauptsitz
Carson City, Nevada, USA
Gegründet
-
Elite Pharmaceuticals Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ELTP. The last closing price for Elite Pharmaceuticals (QB) was US$0,46. Over the last year, Elite Pharmaceuticals (QB) shares have traded in a share price range of US$ 0,1213 to US$ 0,7598.

Elite Pharmaceuticals (QB) currently has 1.068.273.108 shares in issue. The market capitalisation of Elite Pharmaceuticals (QB) is US$494,61 million. Elite Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of 25.00.

ELTP Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

26 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

02 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

18 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

28 Oktober 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

23 Oktober 2024
Edgar (US Regulatory)

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition

ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition     Miami, FL – October 23, 2024 -- InvestorsHub NewsWire – EmergingGrowth.com, a leading...

23 Oktober 2024
InvestorsHub NewsWire

Form 8-K - Current report

10 Oktober 2024
Edgar (US Regulatory)

Form 8-K - Current report

27 August 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.04195-8.225490196080.510.510.458960800.47789695CS
4-0.08565-15.46866534220.55370.5590.4511791970.49803477CS
12-0.05595-10.6774809160.5240.720.4516379680.5586306CS
260.27805146.3421052630.190.75980.162624099050.46423643CS
520.283051530.1850.75980.121316167090.38932917CS
1560.428051070.1250.040.75980.02689882450.2507414CS
2600.37655411.5300546450.09150.75980.0239733280.17530657CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0,46805
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1.068.273.108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 494,61M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0,1213 to US$ 0,7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 25
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 8,87
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56,63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20,11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HOMUHoumu Holdings Ltd (CE)
US$ 0,0025
(249.900,00%)
21,01k
UNDRUnderSea Recovery Corporation (CE)
US$ 0,0009
(89.900,00%)
40k
FDVXFFenixOro Gold Corporation (CE)
US$ 0,035
(34.900,00%)
3k
BYNEFBanyon Tree Holdings Ltd (PK)
US$ 0,241
(30.025,00%)
384
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0,0002
(19.900,00%)
2,35k
PXMDPaxMedica Inc (CE)
US$ 0,000001
(-100,00%)
6,8k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,000001
(-99,99%)
548
NHHSNorthStar Healthcare Income Inc (PK)
US$ 0,0003
(-99,97%)
12,84k
PKLBFPerk Labs Inc (CE)
US$ 0,000001
(-99,67%)
20k
FPPPFieldpoint Petroleum Corp (CE)
US$ 0,000001
(-99,25%)
1,63k
DRNKNoHo Inc (PK)
US$ 0,0001
(0,00%)
555,41M
RONNRonn Motor Group Inc (PK)
US$ 0,0003
(0,00%)
426,45M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
295,45M
HMBLHUMBL Inc (PK)
US$ 0,0006
(-25,00%)
207,91M
DPLSDarkPulse Inc (PK)
US$ 0,0004
(-20,00%)
160,38M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten